EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) stock is trading higher on Monday after the company revealed interim 16-week data ...
Besides Wall Street's top -and-bottom-line estimates for Regeneron (REGN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the ...
On top of this, a stock split generally shows a company is confident about the future, with the idea that the stock could ...
Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. Read More on REGN: Regeneron Pharmaceuticals NewsMORE Related Stocks Indices ...
RBC Capital analyst Gregory Renza maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $362.00. The company’s shares closed last Friday at $316.98. According to ...
Roche's key products like Vabysmo, Ocrevus, and Phesgo are performing well. Read why RHHBY stock looks well positioned to ...
In the latest lawsuit, Apple was awarded $250 in damages – the statutory minimum, which was what the company sought in its ...
Chronic therapy is essential for PCV patients, even after resolution of pigment epithelial detachment, to prevent recurrence. Faricimab and aflibercept show efficacy in DME, RVO, and nAMD, but not all ...
Here in Blighty, with war far away, it is almost impossible to imagine that we were once savvy enough to save the world from Hitler ...
.Ospreys moved off the bottom of the United Rugby Championship table with a hard-fought 22-13 victory over Edinburgh in Bridgend. Whether you’re a fan of the All Blacks, a follower of the women’s game ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback